Number of items: 3.
Sullivan, M; Rybicki, L A; Winter, A; Hoffmann, M M; Reiermann, S; Linke, H; Arbeiter, K; Patzer, L; Budde, K; Hoppe, B; Zeier, M; Lhotta, K; Bock, A; Wiech, T; Gaspert, A; Fehr, T; Woznowski, M; Berisha, G; Malinoc, A; Goek, O N; Eng, C; Neumann, H P H (2011). Age-related penetrance of hereditary atypical hemolytic uremic syndrome. Annals of Human Genetics, 75(6):639-647.
Sullivan, M; Erlic, Z; Hoffmann, M M; Arbeiter, K; Patzer, L; Budde, K; Hoppe, B; Zeier, M; Lhotta, K; Rybicki, L A; Bock, A; Berisha, G; Neumann, H P H (2010). Epidemiological approach to identifying genetic predispositions for atypical hemolytic uremic syndrome. Annals of Human Genetics, 74(1):17-26.
Patzer, L; Hernando, N; Ziegler, U; Beck-Schimmer, B; Biber, J; Murer, H (2006). Ifosfamide metabolites CAA, 4-OH-Ifo and Ifo-mustard reduce apical phosphate transport by changing NaPi-IIa in OK cells. Kidney International, 70(10):1725-1734.
This list was generated on Mon Jun 17 03:22:23 2019 CEST.
